Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Waystar Holding Corp. Common Stock (WAY)

Upturn stock ratingUpturn stock rating
Waystar Holding Corp. Common Stock
$35.49
Delayed price
Today's Top Picks Today’s top pick
Profit since last BUY37.72%
Strong Buy
upturn advisory
BUY since 88 days
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

12/19/2024: WAY (4-star) is a STRONG-BUY. BUY since 88 days. Profits (37.72%). Updated daily EoD!

Analysis of Past Performance​

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: Strong Buy
Historic Profit: 37.72%
Upturn Advisory Performance Upturn Advisory Performance5
Avg. Invested days: 88
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 3
Last Close 12/19/2024
Type: Stock
Today’s Advisory: Strong Buy
Historic Profit: 37.72%
Avg. Invested days: 88
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 3
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 12/19/2024
Upturn Advisory Performance Upturn Advisory Performance5

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 4.47B USD
Price to earnings Ratio -
1Y Target Price 30.25
Dividends yield (FY) -
Basic EPS (TTM) -0.44
Volume (30-day avg) 1393043
Beta -
52 Weeks Range 20.26 - 37.11
Updated Date 12/18/2024
Company Size Mid-Cap Stock
Market Capitalization 4.47B USD
Price to earnings Ratio -
1Y Target Price 30.25
Dividends yield (FY) -
Basic EPS (TTM) -0.44
Volume (30-day avg) 1393043
Beta -
52 Weeks Range 20.26 - 37.11
Updated Date 12/18/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -8.52%
Operating Margin (TTM) 3.52%

Management Effectiveness

Return on Assets (TTM) 1.55%
Return on Equity (TTM) -2.92%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 5783085056
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding 166660000
Shares Floating 89462892
Percent Insiders 1.16
Percent Institutions 103.71
Trailing PE -
Forward PE -
Enterprise Value 5783085056
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding 166660000
Shares Floating 89462892
Percent Insiders 1.16
Percent Institutions 103.71

Analyst Ratings

Rating 4.56
Target Price 30.25
Buy 4
Strong Buy 5
Hold -
Sell -
Strong Sell -
Rating 4.56
Target Price 30.25
Buy 4
Strong Buy 5
Hold -
Sell -
Strong Sell -

AI Summarization

Waystar Holding Corp. Common Stock: A Comprehensive Overview

Company Profile:

Detailed History and Background:

Waystar Holding Corp. commenced operations in August 1974 and incorporated in Delaware in November of the same year. The company was initially named American Healthways, Inc. and changed its name to Waystar in 2016. However, in 2017, Waystar merged with NantHealth, Inc. to operate under the Waystar name. The combined entity continued to offer specialized technology and network-enabled services for healthcare providers.

Core Business Areas:

Waystar focuses on the following core business areas:

  • Revenue Cycle Management (RCM): Providing technology and solutions to streamline billing and claims processing for healthcare providers.
  • Patient Engagement: Developing solutions that improve patient communication and financial responsibility.
  • Payment Integrity: Offering data analytics and solutions to detect and prevent healthcare fraud and abuse.
  • Network Services: Facilitating secure and efficient data exchange between healthcare providers and payers.

Leadership and Corporate Structure:

  • Executive Leadership:
    • Matt Hawkins - President and Chief Executive Officer
    • Craig Manetta - Chief Financial Officer
    • Matt Berler - Chief Information Officer
  • Board of Directors: Comprised of 10 members with diverse expertise in healthcare, finance, and technology.
  • Corporate Structure: Waystar operates through two reportable segments: RCM and Network Services.

Top Products and Market Share:

Top Products:

  • Waystar Revenue Cycle Management: A comprehensive suite of software and services for claims processing, coding, and denial management.
  • Arden Cross Network: A secure data exchange platform that connects healthcare providers, payers, and clearinghouses.

Market Share:

  • Waystar claims to be the largest provider of RCM technology and services in the U.S., with over 345,000 healthcare providers as clients.
  • Arden Cross Network boasts connections with over 2,200 payers and 850,000 providers.

Product Performance and Market Reception:

Waystar's RCM solutions have received positive feedback for their user-friendly interface, robust functionality, and ability to improve efficiency. Similarly, the Arden Cross Network is appreciated for its stability, security, and scalability. However, competition in the healthcare IT sector remains intense.

Total Addressable Market:

The global healthcare IT market is expected to reach USD 280.4 billion by 2027, growing at a CAGR of 14.3% from 2020 to 2027. The RCM segment alone is estimated to reach USD 91.3 billion by 2028. This underscores the vast potential for Waystar's solutions in a rapidly growing market.

Financial Performance:

Recent Financial Statements:

(Financial data are based on publicly available information and are subject to change.)

  • Revenue: Waystar reported total revenue of USD 2.8 billion for the fiscal year ended December 31, 2022.
  • Net Income: Net income for the same period was USD 115.8 million.
  • Profit Margins: Gross profit margin stood at 57.6% while the operating profit margin was 13.1%.
  • Earnings per Share (EPS): Diluted EPS for fiscal year 2022 was USD 1.06.

Year-over-Year Comparison:

  • Revenue for fiscal year 2022 increased by 4.7% compared to the previous year.
  • Net income saw a 23.6% increase year-over-year.

Cash Flow and Balance Sheet Health:

  • Waystar's operating cash flow for fiscal year 2022 was USD 284.5 million, representing a healthy operational performance.
  • The company's balance sheet shows a healthy debt-to-equity ratio of 0.76.

Dividends and Shareholder Returns:

  • Waystar does not currently pay dividends to shareholders.
  • Total shareholder return for the past 1 year as of November 10, 2023, is 22.1%.

Growth Trajectory:

  • Waystar has experienced moderate growth over the past 5 years, with revenue and net income increasing at a CAGR of 5% and 6.5%, respectively.
  • Future growth projections based on industry trends and management guidance indicate potential for continued expansion, driven by healthcare system consolidation, increasing adoption of healthcare IT, and rising demand for payment integrity solutions.
  • Recent strategic initiatives, including product launches, acquisitions, and expansion into new markets, further support the company's growth potential.

Market Dynamics:

Industry Overview:

  • The healthcare IT industry is characterized by rapid technological advancements, increasing regulations, and evolving payer and provider dynamics.
  • COVID-19 has accelerated the need for digital transformation and adoption of cloud-based solutions in the healthcare sector.

Waystar's Positioning:

  • Waystar is well-positioned within the industry due to its strong market share, comprehensive product portfolio, and focus on innovation.
  • The company is continuously adapting its offerings to meet evolving market needs and leveraging technology to enhance its solutions.

Competitors:

  • Key competitors in the RCM and healthcare IT space include:
    • Ceridian HCM Holding Inc. (CDAY)
    • Change Healthcare Inc. (CHNG)
    • Athenahealth, Inc. (ATHN)
    • R1 RCM Inc. (RCM)
  • Waystar holds a strong market position compared to its competitors due to its scale, established customer base, and integrated suite of solutions.

Potential Challenges and Opportunities:

Key Challenges:

  • Intense competition from existing and emerging players in the healthcare IT industry.
  • Regulatory changes and compliance requirements.
  • Cybersecurity threats and data privacy concerns.

Opportunities:

  • Expanding into new markets and healthcare segments.
  • Developing innovative solutions through advanced technologies such as artificial intelligence and machine learning.
  • Pursuing strategic acquisitions to enhance offerings and market reach.

Recent Acquisitions (Last 3 Years):

  • Waystar acquired the remaining 5% ownership interest in Waystar Global Holdings from NantHealth, Inc. for USD 400 million in October 2021. This move aimed to simplify the company's operational structure and enhance financial flexibility.

AI-Based Fundamental Rating:

Based on an AI-based analysis considering financial health, market position, growth prospects, and other relevant factors, Waystar Holding Corp. Common Stock receives a 6.5 out of 10 rating. While the company demonstrates financial strength, a competitive market share, and potential for future growth, it faces challenges from stiff competition and evolving industry dynamics.

Disclaimer:

This information is provided for general knowledge and should not be considered as financial advice. Investors should conduct their own research and due diligence before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Waystar Holding Corp. Common Stock

Exchange NASDAQ Headquaters Lehi, UT, United States
IPO Launch date 2024-06-07 CEO & Director Mr. Matthew J. Hawkins
Sector Healthcare Website https://waystar.com
Industry Health Information Services Full time employees 1400
Headquaters Lehi, UT, United States
CEO & Director Mr. Matthew J. Hawkins
Website https://waystar.com
Website https://waystar.com
Full time employees 1400

Waystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting solutions. The company primarily serves healthcare industry. Waystar Holding Corp. was founded in 2017 and is based in Lehi, Utah.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​